MedPath

CIPROFLOXACIN INTRAVENOUS INFUSION

CIPROFLOXACIN INTRAVENOUS INFUSION

Discontinued
DIN Number

02267462

Drug Class

Human

Market Date

May 22, 2008

Company
HC

teva canada limited

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02267462
AIG Number0123207007
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
J01MA02 CIPROFLOXACIN
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification08:12.18
Health Canada Classification

ACTIVE INGREDIENTS (1)

CIPROFLOXACINActive
Strength: 2 MG / ML
Monograph: CIPROFLOXACIN

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.